Buck Wealth Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.8K Buy
+1,107
New +$63.6K 0.01% 321
2025
Q4
Sell
-16,437
Closed -$741K 177
2025
Q3
$741K Sell
16,437
-4,070
-20% -$190K 0.1% 95
2025
Q2
$949K Buy
+20,507
New +$1.01M 0.14% 78

Other funds holding BMY

Buck Wealth Strategies's BMY Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 1,107 shares worth $63.8K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in BMY as recently as Q3 2025.

Buck Wealth Strategies first reported a position in BMY in Q2 2025 and has held it in 3 quarters since. The position peaked at $949K in Q2 2025. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Buck Wealth Strategies held 1,107 shares of Bristol-Myers Squibb worth $63.8K as of Q2 2026.
  • Bristol-Myers Squibb was a new Buck Wealth Strategies position in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #321 holding.
  • Buck Wealth Strategies first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 3 quarters since.
  • Buck Wealth Strategies's Bristol-Myers Squibb position peaked at $949K in Q2 2025.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.